https://www.selleckchem.com/pr....oducts/talabostat.ht
miR-155 directly targeted the 3'-UTR of FOXO3 to regulate its expression. Taken together, our data suggest tanshinone IIA ameliorates inflammation response in OA via inhibition of the miR-155/FOXO3 axis, and provide some evidences that tanshinone IIA could be designed and developed as a new promising clinical therapeutic drug for OA patients. Taken together, our data suggest tanshinone IIA ameliorates inflammation response in OA via inhibition of the miR-155/FOXO3 axis, and provide some evidences that tanshinone IIA could be designed
Like
Comment
Share
